Treatment adherence in pediatric eosinophilic gastrointestinal disorders

J Pediatr Psychol. 2012 Jun;37(5):533-42. doi: 10.1093/jpepsy/jsr090. Epub 2011 Nov 10.

Abstract

Objective: Examine treatment adherence rates in pediatric eosinophilic gastrointestinal disorders (EGID).

Methods: Participants were children aged 2.5-18 years with eosinophilic esophagitis or eosinophilic gastroenteritis (EGE) and their caregivers. A multimethod, multi-informant assessment including parent report and electronic monitoring was utilized, with a 90% cut point for nonadherence.

Results: Medication nonadherence prevalence was 30%. Adherence frequency was 91% ± 14% (0-100%) per parent report and 100% ± 69% (0-194%) per electronic monitors. Tube-feeding adherence was 99% ± 3%. Food allergen exposures were less than 1 per 2 weeks, with 33% nonadherence prevalence. Patients with EGE and toddlers with both conditions demonstrated poorer medication adherence (p's < .05). Caregivers reported higher number of missed medication doses than food exposures (p < .05).

Conclusions: The prevalence and range of nonadherence demonstrates that subsets of these patients are nonadherent. Adherence to treatment in EGID is complex and multifaceted, with nonadherence varying across treatments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Enteritis / therapy*
  • Eosinophilia / therapy*
  • Eosinophilic Esophagitis / therapy*
  • Female
  • Gastritis / therapy*
  • Humans
  • Male
  • Middle Aged
  • Parents
  • Patient Compliance / statistics & numerical data*
  • Surveys and Questionnaires

Supplementary concepts

  • Eosinophilic enteropathy